<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To investigate the effects of the clustering of components of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> (MS) on development of <z:mp ids='MP_0002055'>diabetes</z:mp>, we examined 3298 Japanese male office workers aged 35-59 years who did not have type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (a fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> level of &gt; or =7.0 mmol/l or receipt of hypoglycemic medication) or a history of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> levels were measured at periodic annual health examinations from May 1994 through May 2001 </plain></SENT>
<SENT sid="2" pm="."><plain>After adjustment for potential risk factors for <z:mp ids='MP_0002055'>diabetes</z:mp>, the multivariate-adjusted relative risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> compared with the subjects without components of the MS was 1.58 (95% CI: 1.08-2.32), 2.48 (95% CI: 1.69-3.63), 3.10 (95% CI: 2.05-4.68), and 5.22 (95% CI: 3.49-7.83) (P-value for trend &lt;0.001) for those with 1, 2, 3, and &gt; or =4 components, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>Even after the subjects were stratified according to fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> level, the clustering of components of the MS was associated with an increased risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> for subjects in <z:hpo ids='HP_0000001'>all</z:hpo> three categories of low-<z:mpath ids='MPATH_458'>normal</z:mpath> fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> (a fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> level of &lt;5.1 mmol/l), high-<z:mpath ids='MPATH_458'>normal</z:mpath> fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> (a fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> level of 5.0-6.0 mmol/l), and impaired fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> (a fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> level of 6.1-6.9 mmol/l) </plain></SENT>
<SENT sid="4" pm="."><plain>These results indicate that clustering of components of the MS associated with <z:mp ids='MP_0002055'>diabetes</z:mp> precedes an increase in the risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in Japanese men </plain></SENT>
</text></document>